Company Analysis Gelesis Holdings, Inc.
1. Summary
Advantages
- Price (0.202 $) is less than fair price (2.87 $)
Disadvantages
- Dividends (0%) are below the sector average (1.26%).
- The stock's return over the last year (-99.74%) is lower than the sector average (-21.87%).
- The company's current efficiency (ROE=-552.36%) is lower than the sector average (ROE=-83.36%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Gelesis Holdings, Inc. | Healthcare | Index | |
---|---|---|---|
7 days | 22.7% | -35.8% | 0.9% |
90 days | -95.5% | -21% | 8.8% |
1 year | -99.7% | -21.9% | 12% |
GLS vs Sector: Gelesis Holdings, Inc. has significantly underperformed the "Healthcare" sector by -77.88% over the past year.
GLS vs Market: Gelesis Holdings, Inc. has significantly underperformed the market by -111.78% over the past year.
Slightly volatile price: GLS is more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: GLS with weekly volatility of -1.92% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.202 $) is lower than the fair price (2.87 $).
Price significantly below the fair price: The current price (0.202 $) is 1320.8% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (53.14).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (62.2).
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.68) is lower than that of the sector as a whole (10.86).
P/BV vs Market: The company's P/BV (3.68) is lower than that of the market as a whole (20.84).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.13) is lower than that of the sector as a whole (4.06).
P/S vs Market: The company's P/S indicator (2.13) is lower than that of the market as a whole (16.02).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-0.65) is lower than that of the sector as a whole (16.98).
EV/Ebitda vs Market: The company's EV/Ebitda (-0.65) is lower than that of the market as a whole (27.16).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 38.58% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (38.58%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.32%).
5.4. ROE
ROE vs Sector: The company's ROE (-552.36%) is lower than that of the sector as a whole (-83.36%).
ROE vs Market: The company's ROE (-552.36%) is lower than that of the market as a whole (43.08%).
5.5. ROA
ROA vs Sector: The company's ROA (-51.79%) is lower than that of the sector as a whole (6.41%).
ROA vs Market: The company's ROA (-51.79%) is lower than that of the market as a whole (23.27%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.29%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.26%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription